NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Let me save you some time. Jondoek is not counting stable disease nor shrinkage after tumor t-cell infiltration enlargement a "response."

He is also not counting longevity, immune response or many other indicators a "response."

Instead he is referring to "Overall Response Rate." He has a point, but it is antiquated and misleading in the field of immunotherapy, particularly in the case where stabilization and/or enlargement due to T-cell infiltration followed by shrinkage or stabilization is often seen. In some cases, with great duration.

The scientific measurement criteria are not always keeping pace with actual patient improvement, but they are improving.